BERLIN, Feb 17 (Reuters) – Bayer’s U.S. class settlement aimed at resolving current and future claims that Roundup weedkiller caused non‑Hodgkin lymphoma is an important addition to its Supreme Court case, Bayer CEO Bill Anderson said on Tuesday.
“We are entering into the settlement because it is an important addition to the case before the Supreme Court, thereby minimising the legal risks as comprehensively as possible,” he said.
“Both elements are necessary independently of each other and reinforce each other,” he added.
(Writing by Friederike HeineEditing by David Goodman)
Comments